174 related articles for article (PubMed ID: 29407631)
1. Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome.
Nie XY; Li JL; Qin SB; Fu Y; Liang GK; Shi LW; Shao H; Liu J; Lu Y
Thromb Res; 2018 Mar; 163():77-82. PubMed ID: 29407631
[TBL] [Abstract][Full Text] [Related]
2. Study of the Association of PEAR1, P2Y12, and UGT2A1 Polymorphisms with Platelet Reactivity in Response to Dual Antiplatelet Therapy in Chinese Patients.
Zhang S; Zhu J; Li H; Wang L; Niu J; Zhu B; He L; Shen L; Qin S; Fang S
Cardiology; 2018; 140(1):21-29. PubMed ID: 29635252
[TBL] [Abstract][Full Text] [Related]
3. Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention.
Yao Y; Tang XF; Zhang JH; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Chen J; Wang M; Xu B; Gao RL; Yuan JQ
Thromb Res; 2016 May; 141():28-34. PubMed ID: 26962983
[TBL] [Abstract][Full Text] [Related]
4. Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.
Peng LL; Zhao YQ; Zhou ZY; Jin J; Zhao M; Chen XM; Chen LY; Cai YF; Li JL; Huang M
Acta Pharmacol Sin; 2016 Nov; 37(11):1442-1448. PubMed ID: 27641736
[TBL] [Abstract][Full Text] [Related]
5. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
[TBL] [Abstract][Full Text] [Related]
6. Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI.
Stimpfle F; Bauer M; Rath D; Schaeffeler E; Schwab M; Gawaz M; Winter S; Geisler T
Front Pharmacol; 2018; 9():490. PubMed ID: 29867494
[No Abstract] [Full Text] [Related]
7. CYP2C19*2 and Other Allelic Variants Affecting Platelet Response to Clopidogrel Tested by Thrombelastography in Patients with Acute Coronary Syndrome.
Liu J; Nie XY; Zhang Y; Lu Y; Shi LW; Wang WM
Chin Med J (Engl); 2015 Aug; 128(16):2183-8. PubMed ID: 26265611
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.
Zhang L; Chen Y; Jin Y; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Li X; Li Y; Zhang Y; Lu C; Yin T
Thromb Res; 2013 Jul; 132(1):81-7. PubMed ID: 23726091
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
Lewis JP; Ryan K; O'Connell JR; Horenstein RB; Damcott CM; Gibson Q; Pollin TI; Mitchell BD; Beitelshees AL; Pakzy R; Tanner K; Parsa A; Tantry US; Bliden KP; Post WS; Faraday N; Herzog W; Gong Y; Pepine CJ; Johnson JA; Gurbel PA; Shuldiner AR
Circ Cardiovasc Genet; 2013 Apr; 6(2):184-92. PubMed ID: 23392654
[TBL] [Abstract][Full Text] [Related]
10. Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.
Baturina O; Andreev D; Fedina L; Mirzaev K; Ivashchenko D; Ryzhikova K; Grishina E; Bochkov P; Shevchenko R; Sychev D
Pharmacology; 2022; 107(3-4):216-226. PubMed ID: 35073541
[TBL] [Abstract][Full Text] [Related]
11. Effect of PEAR1, PTGS1 gene polymorphisms on the recurrence of aspirin-treated patients with ischemic stroke in the Han population of China: A 4-year follow-up study.
Zhang L; Meng Z; Wang H; Miao Y
Medicine (Baltimore); 2024 May; 103(19):e38031. PubMed ID: 38728491
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of
Zhang X; Li S; Zhao Y; Tang N; Jia T; Zhou P; Liu J; Shi L; Lu CY; Nie X
Pharmacogenomics; 2021 Jul; 22(10):641-648. PubMed ID: 34075782
[No Abstract] [Full Text] [Related]
13. Association of PEAR1 rs12041331 polymorphism and pharmacodynamics of ticagrelor in healthy Chinese volunteers.
Li M; Hu Y; Wen Z; Li H; Hu X; Zhang Y; Zhang Z; Xiao J; Tang J; Chen X
Xenobiotica; 2017 Dec; 47(12):1130-1138. PubMed ID: 27937053
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
Mega JL; Close SL; Wiviott SD; Shen L; Walker JR; Simon T; Antman EM; Braunwald E; Sabatine MS
Lancet; 2010 Oct; 376(9749):1312-9. PubMed ID: 20801494
[TBL] [Abstract][Full Text] [Related]
15. Effect of PEAR1 Genetic Variants on 1-Year Outcomes in Chinese Patients with Acute Myocardial Infarction After Percutaneous Coronary Intervention.
Yao Y; Tang XF; He C; Song Y; Xu JJ; Meng XM; Xu B; Gao RL; Yuan JQ
J Atheroscler Thromb; 2018 May; 25(5):454-459. PubMed ID: 29212986
[TBL] [Abstract][Full Text] [Related]
16. The Frequency of the Minor Polymorphisms in the
Zelenskaya EM; Lifshits GI; Nikolaev KY; Donirova OS; Altayev VD; Apartsin KA; Voronina EN; Protasov KV; Sychev DA
Genet Test Mol Biomarkers; 2020 Jun; 24(6):338-342. PubMed ID: 32392440
[No Abstract] [Full Text] [Related]
17. PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish population.
Yang WY; Petit T; Cauwenberghs N; Zhang ZY; Sheng CS; Thijs L; Salvi E; Izzi B; Vandenbriele C; Wei FF; Gu YM; Jacobs L; Citterio L; Delli Carpini S; Barlassina C; Cusi D; Hoylaerts MF; Verhamme P; Kuznetsova T; Staessen JA
BMC Med Genet; 2017 Apr; 18(1):45. PubMed ID: 28449647
[TBL] [Abstract][Full Text] [Related]
18. A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease.
Pi L; Xu Y; Fu L; Zhang L; Liu Y; Zhou H; Che D; Gu X
Ann Hum Genet; 2019 Jan; 83(1):54-62. PubMed ID: 30256383
[TBL] [Abstract][Full Text] [Related]
19. The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients.
Tang N; Yin S; Sun Z; Xu X; Qin J
Scand J Clin Lab Invest; 2015 May; 75(3):223-9. PubMed ID: 25594796
[TBL] [Abstract][Full Text] [Related]
20. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
